KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Shares Outstanding (Weighted Average) (2016 - 2026)

Nu Skin Enterprises' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $49.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 0.74% to $49.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.3 million, a 0.74% decrease, with the full-year FY2025 number at $49.3 million, down 0.74% from a year prior.
  • Shares Outstanding (Weighted Average) hit $49.3 million in Q4 2025 for Nu Skin Enterprises, roughly flat from $49.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NUS hit a ceiling of $50.7 million in Q1 2021 and a floor of $49.3 million in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $49.9 million across 5 years, with a median of $49.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 7.91% in 2021 and later increased 0.46% in 2025.
  • Tracing NUS's Shares Outstanding (Weighted Average) over 5 years: stood at $50.2 million in 2021, then fell by 0.38% to $50.0 million in 2022, then fell by 0.58% to $49.7 million in 2023, then dropped by 0.1% to $49.7 million in 2024, then fell by 0.74% to $49.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NUS at $49.3 million in Q4 2025, $49.5 million in Q3 2025, and $49.6 million in Q2 2025.